Urix Announces DxCG Gesundheitsanalytik GmbH

Leading Provider of Healthcare Analytics Opens German Offic and Appoints Managing Director

BOSTON, April 28, 2008 — Urix, Inc., an ISO business, and leading provider of health care analytics and DxCG risk adjustment methodologies announces the founding of Munich-based DxCG Gesundheitsanalytik GmbH.

DxCG Gesundheitsanalytik GmbH has been established to further provide and develop DxCG risk adjustment tools and methodologies for use in the German market. To lead this initiative, Dr. Thomas Zhan has been appointed as Managing Director of the Munich-based office.

Dr. Zahn has been active for over 20 years in varied sectors of German health care as a scientist, consultant and most recently, as the leader of Accenture Care Management. He will lead the Munich office to effectively customize DxCG’s proven tools to the special needs and changes required by German Healthcare, and to work in conjunction with German partners to develop further as required.

DxCG’s diagnosis-based risk-adjustment methods and predictive modeling tools already support German health care in the improvement of quality and efficiency of care and allow for the building of fairer, risk-adjusted care and reimbursement models.

In the USA, DxCG risk-adjustment methodologies have become a gold standard for its ability to accurately help health care organizations measure costs, quality and improve the delivery of care.

“We are very excited at this opportunity to expand our global operations and improve our ability to provide risk-adjustment tools to the German International market,” said Mike Coyne, president of Urix. “We have noticed a dynamic shift in the role risk adjustment is playing in changing and improving health care in Germany and believe the DxCG methodology has proven to adapt to a multitude of health care systems,” added Coyne.

“Particularly in the current challenging health care situation I, with my team in Munich, would like to help health care companies in Germany use a practical toolkit in analyzing health care risks and prepare it to be effective under future changing financial conditions,“ said Dr. Thomas Zahn, Managing Director of DxCG Gesundheitsanalytik GmbH.

To learn more about DxCG Gesundeitsanalytik and how risk adjustment tools are being used in Germany, A DxCG Predictive Modeling and Risk Adjustment Symposium will be held May 6th and 7th at the Berlin Marriott. Please visit www.dxcg.de to register and learn more about the event.

About Urix® , Inc.
Urix, an ISO business, is a leading independent health care analytics company that offers a portfolio of products to help clients gain insight into their medical data. Urix technology streamlines clients’ data from multiple sources and displays results in a user-friendly, web-based interactive analytics and reporting environment. Urix solutions enable clients to proactively manage their health care costs and risk while improving the quality and effectiveness of care. Health care organizations use Urix’s advanced reporting capabilities for rapid decision-support across many health care business areas. Urix is Where Intelligent Decision Making Begins™.

Release: Immediate

Stephanie Martinovich (Urix)

Archived Press